Trial Profile
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nemonoxacin (Primary)
- Indications Community-acquired pneumonia; Diabetic foot ulcer; Kidney disorders; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Zhejiang Medicine
- 25 Feb 2019 Results published in the Clinical Therapeutics
- 28 Mar 2018 Status changed from recruiting to completed.
- 15 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.